Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03080714 · ClinicalTrials.gov registry record
Triton Agreement and Precision Study
A clinical trial of Eye Diseases and Healthy Eyes, sponsored by Topcon Medical Systems.
- Completed
- Registry status
- 88
- Enrollment target
- 1
- Study location
NCT03080714: Completed study of Eye Diseases and Healthy Eyes, sponsored by Topcon Medical Systems.
NCT03080714 is a study of Eye Diseases and Healthy Eyes that has completed, run by Topcon Medical Systems. The registered enrollment target is 88 participants, below the 741,300-participant average among 27 other Eye Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03080714, a study of Eye Diseases and Healthy Eyes, has completed, sponsored by Topcon Medical Systems.
- COMPLETED
- Registry status
- 88 participants
- Enrollment target
- 1
- Study location
Study Summary
To Compare the agreement and precision between the Topcon DRI OCT Triton and the 3D OCT-1 Maestro with RDB.
Conditions Studied
Interventions
- DEVICE 3D OCT-1 Maestro
- DEVICE Topcon DRI OCT Triton (plus)
Study Locations (1)
Minnesota
- Fischer Laser Eye Center - Willmar
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2017-03-13 |
| Est. Completion | 2017-10-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03080714
The ClinicalTrials.gov registry entry for NCT03080714 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 741,300-participant average among 27 other Eye Diseases trials with a reported enrollment target (100% lower). The listed sponsor is Topcon Medical Systems, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Eye Diseases appearing as the primary indexed condition, and to 2 interventions - of which 3D OCT-1 Maestro is the first listed.
NCT03080714 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT03080714 about?
NCT03080714 is a clinical study titled "Triton Agreement and Precision Study". To Compare the agreement and precision between the Topcon DRI OCT Triton and the 3D OCT-1 Maestro with RDB.
What is the current status of trial NCT03080714?
This trial is currently completed. The enrollment target is 88 participants. The study started on 2017-03-13. Estimated completion is 2017-10-30.
What conditions does trial NCT03080714 study?
This clinical trial studies the following conditions: Eye Diseases, Healthy Eyes.
What interventions are being tested in trial NCT03080714?
The interventions under investigation include: 3D OCT-1 Maestro (DEVICE), Topcon DRI OCT Triton (plus) (DEVICE).
Who is sponsoring clinical trial NCT03080714?
This trial is sponsored by Topcon Medical Systems, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03080714 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eye Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Adaptive Optics Retinal Imaging
RECRUITING
-
Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)
RECRUITING · Phase 3
-
Widefield Confocal Scanning Laser Ophthalmoscope Optimized for Pediatric and Neonatal Imaging
RECRUITING
-
SGLT2 Inhibitors in Geographic Atrophy
RECRUITING · Phase 2
-
Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (SIGHT) 2
RECRUITING · NA
-
IRIS Registry: Intelligent Research in Sight Registry
RECRUITING
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.